[HTML][HTML] Predictors of critical care needs after IV thrombolysis for acute ischemic stroke
Background and Purpose Intravenous (IV) tissue plasminogen activator (tPA) is the only
Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA …
Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA …
[PDF][PDF] Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
R Faigle, A Sharrief, EB Marsh, RH Llinas, VC Urrutia - 2014 - academia.edu
Abstract Background and Purpose: Intravenous (IV) tissue plasminogen activator (tPA) is the
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke.
R Faigle, A Sharrief, EB Marsh, RH Llinas… - PLoS …, 2014 - search.ebscohost.com
Abstract Background and Purpose: Intravenous (IV) tissue plasminogen activator (tPA) is the
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
[PDF][PDF] Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
R Faigle, A Sharrief, EB Marsh, RH Llinas, VC Urrutia - 2014 - Citeseer
Abstract Background and Purpose: Intravenous (IV) tissue plasminogen activator (tPA) is the
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
[引用][C] Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
R Faigle, A Sharrief, EB Marsh, RH Llinas… - PLoS …, 2014 - ui.adsabs.harvard.edu
Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke - NASA/ADS
Now on home page ads icon ads Enable full ADS view NASA/ADS Predictors of Critical Care …
Now on home page ads icon ads Enable full ADS view NASA/ADS Predictors of Critical Care …
[HTML][HTML] Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
R Faigle, A Sharrief, EB Marsh, RH Llinas, VC Urrutia - PLoS ONE, 2014 - ncbi.nlm.nih.gov
Background and Purpose Intravenous (IV) tissue plasminogen activator (tPA) is the only
Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA …
Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA …
[PDF][PDF] Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
R Faigle, A Sharrief, EB Marsh, RH Llinas, VC Urrutia - 2014 - pdfs.semanticscholar.org
Abstract Background and Purpose: Intravenous (IV) tissue plasminogen activator (tPA) is the
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
[PDF][PDF] Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
R Faigle, A Sharrief, EB Marsh, RH Llinas, VC Urrutia - 2014 - researchgate.net
Abstract Background and Purpose: Intravenous (IV) tissue plasminogen activator (tPA) is the
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
R Faigle, A Sharrief, EB Marsh, RH Llinas, VC Urrutia - PLoS ONE, 2014 - go.gale.com
Ischemic stroke is the second leading cause of death for people older than 60 years of age,
with an estimated 795,000 new strokes each year in the United States alone [1],[2]. Thus …
with an estimated 795,000 new strokes each year in the United States alone [1],[2]. Thus …
Predictors of critical care needs after IV thrombolysis for acute ischemic stroke
R Faigle, A Sharrief, EB Marsh, RH Llinas, VC Urrutia - PLoS ONE, 2014 - hero.epa.gov
BACKGROUND AND PURPOSE: Intravenous (IV) tissue plasminogen activator (tPA) is the
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …
only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke …